Exact Mass: 895.4022

Exact Mass Matches: 895.4022

Found 27 metabolites which its exact mass value is equals to given mass value 895.4022, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Globulin G

2-(6-amino-2-{4-carbamoyl-4-[2-(2-{[3-(carboxyamino)-5-{[4,5-dihydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)oxan-2-yl]oxy}-2-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}propanamido)propanamido]butanamido}hexanamido)propanoic acid

C36H61N7O19 (895.4022)

Biie-0246

5-Carbamimidamido-N-[2-(3,5-dioxo-1,2-diphenyl-1,2,4-triazolidin-4-yl)ethyl]-2-[(1-hydroxy-2-{1-[2-(4-{10-hydroxy-9-azatricyclo[9.4.0.0,]pentadeca-1(15),3,5,7,9,11,13-heptaen-2-yl}piperazin-1-yl)-2-oxoethyl]cyclopentyl}ethylidene)amino]pentanimidate

C49H57N11O6 (895.4493)

Enopeptin A

C47H57N7O11 (895.4116)

methyl 2-(3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl)-2-[2-(2,3-dimethyloxiran-2-yl)-11-hydroxy-9-[5-(5-hydroxy-4-methoxy-6-methyloxan-2-yl)oxy-4,6-dimethyl-4-(methylamino)oxan-2-yl]-4,7,12-trioxonaphtho[2,3-h]chromen-5-yl]acetate

methyl 2-(3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl)-2-[2-(2,3-dimethyloxiran-2-yl)-11-hydroxy-9-[5-(5-hydroxy-4-methoxy-6-methyloxan-2-yl)oxy-4,6-dimethyl-4-(methylamino)oxan-2-yl]-4,7,12-trioxonaphtho[2,3-h]chromen-5-yl]acetate

C46H57NO17 (895.3626)

5-(diaminomethylideneamino)-N-[2-(3,5-dioxo-1,2-diphenyl-1,2,4-triazolidin-4-yl)ethyl]-2-[[2-[1-[2-oxo-2-[4-(6-oxo-5,11-dihydrobenzo[c][1]benzazepin-11-yl)piperazin-1-yl]ethyl]cyclopentyl]acetyl]amino]pentanamide

5-(diaminomethylideneamino)-N-[2-(3,5-dioxo-1,2-diphenyl-1,2,4-triazolidin-4-yl)ethyl]-2-[[2-[1-[2-oxo-2-[4-(6-oxo-5,11-dihydrobenzo[c][1]benzazepin-11-yl)piperazin-1-yl]ethyl]cyclopentyl]acetyl]amino]pentanamide

C49H57N11O6 (895.4493)

CDP-1,2-dimyristoylglycerol

C40H71N3O15P2-2 (895.436)

CID 168510931

C36H61N7O19 (895.4022)

CID 168511254

C35H61N9O18 (895.4134)

CID 168510974

C35H61N9O18 (895.4134)

CID 168511099

C36H61N7O19 (895.4022)

BIIE-0246

C49H57N11O6 (895.4493)

BIIE-0246 (AR-H 053591) is a potent and selective NPY2R (neuropeptide Y receptor 2) antagonist with an IC50 value of 15 nM for rat [125I]PYY3-36. BIIE-0246 decreases the expression of p-AKT S473, P-p44/42 MAPK under the NPY-stimulated. BIIE-0246 reduces albuminuria in ADR nephropathy[1][2][3].

(2r)-n-[(2s,5s,8s,11r,12s,15s,18s,21r)-2,8-bis[(2s)-butan-2-yl]-15-(3-carbamimidamidopropyl)-5-[(3-chloro-4-hydroxyphenyl)methyl]-6,13,16,21-tetrahydroxy-4,11-dimethyl-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2,3-dihydroxypropanimidic acid

(2r)-n-[(2s,5s,8s,11r,12s,15s,18s,21r)-2,8-bis[(2s)-butan-2-yl]-15-(3-carbamimidamidopropyl)-5-[(3-chloro-4-hydroxyphenyl)methyl]-6,13,16,21-tetrahydroxy-4,11-dimethyl-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2,3-dihydroxypropanimidic acid

C40H62ClN9O12 (895.4206)

methyl 2-[2-(2,3-dimethyloxiran-2-yl)-11-hydroxy-10-[(2r,4s,5s,6s)-5-{[(2r,4s,5r,6r)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-4,6-dimethyl-4-(methylamino)oxan-2-yl]-4,7,12-trioxo-1-oxatetraphen-5-yl]-2-hydroxy-2-[(2s,4s,5r,6r)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]acetate

methyl 2-[2-(2,3-dimethyloxiran-2-yl)-11-hydroxy-10-[(2r,4s,5s,6s)-5-{[(2r,4s,5r,6r)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-4,6-dimethyl-4-(methylamino)oxan-2-yl]-4,7,12-trioxo-1-oxatetraphen-5-yl]-2-hydroxy-2-[(2s,4s,5r,6r)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]acetate

C46H57NO17 (895.3626)

(2r)-n-[(2s,5s,8s,11r,12s,15s,18r,21r)-15-(3-carbamimidamidopropyl)-5-[(3-chloro-4-hydroxyphenyl)methyl]-6,13,16,21-tetrahydroxy-4,11-dimethyl-3,9,22-trioxo-2,8-bis(sec-butyl)-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2,3-dihydroxypropanimidic acid

(2r)-n-[(2s,5s,8s,11r,12s,15s,18r,21r)-15-(3-carbamimidamidopropyl)-5-[(3-chloro-4-hydroxyphenyl)methyl]-6,13,16,21-tetrahydroxy-4,11-dimethyl-3,9,22-trioxo-2,8-bis(sec-butyl)-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2,3-dihydroxypropanimidic acid

C40H62ClN9O12 (895.4206)

methyl 2-[2-(2,3-dimethyloxiran-2-yl)-11-hydroxy-10-{5-[(5-hydroxy-4-methoxy-6-methyloxan-2-yl)oxy]-4,6-dimethyl-4-(methylamino)oxan-2-yl}-4,7,12-trioxo-1-oxatetraphen-5-yl]-2-hydroxy-2-(5-hydroxy-4-methoxy-6-methyloxan-2-yl)acetate

methyl 2-[2-(2,3-dimethyloxiran-2-yl)-11-hydroxy-10-{5-[(5-hydroxy-4-methoxy-6-methyloxan-2-yl)oxy]-4,6-dimethyl-4-(methylamino)oxan-2-yl}-4,7,12-trioxo-1-oxatetraphen-5-yl]-2-hydroxy-2-(5-hydroxy-4-methoxy-6-methyloxan-2-yl)acetate

C46H57NO17 (895.3626)

(2e,4e,6e,8e,10e)-n'-(2-hydroxy-5-oxocyclopent-1-en-1-yl)-n-[(1s)-1-{[(3s,7s,9r,13s,16s,19s)-15-hydroxy-9,13,16,17-tetramethyl-2,6,12,18-tetraoxo-5-oxa-1,11,14,17-tetraazatricyclo[17.3.0.0⁷,¹¹]docos-14-en-3-yl]-c-hydroxycarbonimidoyl}-2-phenylethyl]dodeca-2,4,6,8,10-pentaenediimidic acid

(2e,4e,6e,8e,10e)-n'-(2-hydroxy-5-oxocyclopent-1-en-1-yl)-n-[(1s)-1-{[(3s,7s,9r,13s,16s,19s)-15-hydroxy-9,13,16,17-tetramethyl-2,6,12,18-tetraoxo-5-oxa-1,11,14,17-tetraazatricyclo[17.3.0.0⁷,¹¹]docos-14-en-3-yl]-c-hydroxycarbonimidoyl}-2-phenylethyl]dodeca-2,4,6,8,10-pentaenediimidic acid

C47H57N7O11 (895.4116)

n-[9-benzyl-5,8,14,17-tetrahydroxy-6-(1-hydroxyethyl)-3-[({2-[(1-hydroxyethylidene)amino]acetyl}oxy)methyl]-12-(4-methoxyphenyl)-10,19-dimethyl-2,11-dioxo-15-(sec-butyl)-1-oxa-4,7,10,13,16-pentaazacyclononadeca-4,7,13,16-tetraen-18-yl]-2-methylpropanimidic acid

n-[9-benzyl-5,8,14,17-tetrahydroxy-6-(1-hydroxyethyl)-3-[({2-[(1-hydroxyethylidene)amino]acetyl}oxy)methyl]-12-(4-methoxyphenyl)-10,19-dimethyl-2,11-dioxo-15-(sec-butyl)-1-oxa-4,7,10,13,16-pentaazacyclononadeca-4,7,13,16-tetraen-18-yl]-2-methylpropanimidic acid

C44H61N7O13 (895.4327)

(2r)-n-[(2s,5s,8s,11r,12s,15s,18s,21r)-2-[(2s)-butan-2-yl]-15-(3-carbamimidamidopropyl)-5-[(3-chloro-4-methoxyphenyl)methyl]-6,13,16,21-tetrahydroxy-8-isopropyl-4,11-dimethyl-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2,3-dihydroxypropanimidic acid

(2r)-n-[(2s,5s,8s,11r,12s,15s,18s,21r)-2-[(2s)-butan-2-yl]-15-(3-carbamimidamidopropyl)-5-[(3-chloro-4-methoxyphenyl)methyl]-6,13,16,21-tetrahydroxy-8-isopropyl-4,11-dimethyl-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2,3-dihydroxypropanimidic acid

C40H62ClN9O12 (895.4206)

n-[15-(3-carbamimidamidopropyl)-5-[(3-chloro-4-hydroxyphenyl)methyl]-6,13,16,21-tetrahydroxy-4,11-dimethyl-3,9,22-trioxo-2,8-bis(sec-butyl)-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2,3-dihydroxypropanimidic acid

n-[15-(3-carbamimidamidopropyl)-5-[(3-chloro-4-hydroxyphenyl)methyl]-6,13,16,21-tetrahydroxy-4,11-dimethyl-3,9,22-trioxo-2,8-bis(sec-butyl)-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2,3-dihydroxypropanimidic acid

C40H62ClN9O12 (895.4206)

(2e,4e,6e,8e,10e)-n'-(2-hydroxy-5-oxocyclopent-1-en-1-yl)-n-[(1s)-1-{[(7s,9r,13s,16s,19s)-15-hydroxy-9,13,16,17-tetramethyl-2,6,12,18-tetraoxo-5-oxa-1,11,14,17-tetraazatricyclo[17.3.0.0⁷,¹¹]docos-14-en-3-yl]-c-hydroxycarbonimidoyl}-2-phenylethyl]dodeca-2,4,6,8,10-pentaenediimidic acid

(2e,4e,6e,8e,10e)-n'-(2-hydroxy-5-oxocyclopent-1-en-1-yl)-n-[(1s)-1-{[(7s,9r,13s,16s,19s)-15-hydroxy-9,13,16,17-tetramethyl-2,6,12,18-tetraoxo-5-oxa-1,11,14,17-tetraazatricyclo[17.3.0.0⁷,¹¹]docos-14-en-3-yl]-c-hydroxycarbonimidoyl}-2-phenylethyl]dodeca-2,4,6,8,10-pentaenediimidic acid

C47H57N7O11 (895.4116)

n-[15-(3-carbamimidamidopropyl)-5-[(3-chloro-4-methoxyphenyl)methyl]-6,13,16,21-tetrahydroxy-8-isopropyl-4,11-dimethyl-3,9,22-trioxo-2-(sec-butyl)-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2,3-dihydroxypropanimidic acid

n-[15-(3-carbamimidamidopropyl)-5-[(3-chloro-4-methoxyphenyl)methyl]-6,13,16,21-tetrahydroxy-8-isopropyl-4,11-dimethyl-3,9,22-trioxo-2-(sec-butyl)-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2,3-dihydroxypropanimidic acid

C40H62ClN9O12 (895.4206)

(2e,4e,6e,8e,10e)-n'-(2-hydroxy-5-oxocyclopent-1-en-1-yl)-n-[1-({15-hydroxy-9,13,16,17-tetramethyl-2,6,12,18-tetraoxo-5-oxa-1,11,14,17-tetraazatricyclo[17.3.0.0⁷,¹¹]docos-14-en-3-yl}-c-hydroxycarbonimidoyl)-2-phenylethyl]dodeca-2,4,6,8,10-pentaenediimidic acid

(2e,4e,6e,8e,10e)-n'-(2-hydroxy-5-oxocyclopent-1-en-1-yl)-n-[1-({15-hydroxy-9,13,16,17-tetramethyl-2,6,12,18-tetraoxo-5-oxa-1,11,14,17-tetraazatricyclo[17.3.0.0⁷,¹¹]docos-14-en-3-yl}-c-hydroxycarbonimidoyl)-2-phenylethyl]dodeca-2,4,6,8,10-pentaenediimidic acid

C47H57N7O11 (895.4116)